Quadrature Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-47,340
| Closed | -$13.9M | – | 1712 |
|
|
2026
Q1 | $13.9M | Sell |
47,340
-5,444
| -10% | -$1.79M | 0.16% | 126 |
|
|
2025
Q4 | $18.5M | Sell |
52,784
-64,090
| -55% | -$21.7M | 0.19% | 104 |
|
|
2025
Q3 | $37.8M | Buy |
116,874
+39,630
| +51% | +$12.3M | 0.45% | 55 |
|
|
2025
Q2 | $30M | Buy |
+77,244
| New | +$31.1M | 0.52% | 50 |
|
|
2025
Q1 | – | Sell |
-319,980
| Closed | -$118M | – | 1175 |
|
|
2024
Q4 | $118M | Buy |
319,980
+297,366
| +1,315% | +$124M | 2.36% | 6 |
|
|
2024
Q3 | $11.8M | Buy |
22,614
+8,182
| +57% | +$4.37M | 0.27% | 75 |
|
|
2024
Q2 | $7.82M | Buy |
14,432
+4,364
| +43% | +$2.31M | 0.13% | 138 |
|
|
2024
Q1 | $5.22M | Sell |
10,068
-15,985
| -61% | -$7.95M | 0.09% | 168 |
|
|
2023
Q4 | $12.3M | Sell |
26,053
-67,838
| -72% | -$31.4M | 0.22% | 81 |
|
|
2023
Q3 | $40.9M | Sell |
93,891
-12,128
| -11% | -$5.5M | 0.84% | 27 |
|
|
2023
Q2 | $47.1M | Buy |
106,019
+9,643
| +10% | +$4.45M | 1.03% | 19 |
|
|
2023
Q1 | $44.3M | Buy |
96,376
+58,886
| +157% | +$28M | 1.21% | 11 |
|
|
2022
Q4 | $19.2M | Buy |
37,490
+19,807
| +112% | +$10.1M | 0.57% | 39 |
|
|
2022
Q3 | $8.05M | Buy |
+17,683
| New | +$8.46M | 0.26% | 102 |
|
|
2021
Q3 | – | Sell |
-6,622
| Closed | -$2.53M | – | 776 |
|
|
2021
Q2 | $2.53M | Sell |
6,622
-6,943
| -51% | -$2.65M | 0.1% | 158 |
|
|
2021
Q1 | $4.87M | Buy |
+13,565
| New | +$4.36M | 0.24% | 90 |
|
|
2020
Q4 | – | Sell |
-32,394
| Closed | -$8.69M | – | 882 |
|
|
2020
Q3 | $8.69M | Buy |
32,394
+9,697
| +43% | +$2.61M | 0.5% | 49 |
|
|
2020
Q2 | $5.97M | Buy |
+22,697
| New | +$6.06M | 0.68% | 24 |
|
|
2020
Q1 | – | Sell |
-1,152
| Closed | -$348K | – | 553 |
|
|
2019
Q4 | $348K | Sell |
1,152
-78,047
| -99% | -$21.5M | 0.01% | 379 |
|
|
2019
Q3 | $19M | Buy |
+79,199
| New | +$21.7M | 0.92% | 24 |
|
|
2019
Q2 | – | Sell |
-51,971
| Closed | -$14.9M | – | 498 |
|
|
2019
Q1 | $14.9M | Buy |
51,971
+46,547
| +858% | +$13.5M | 1.28% | 15 |
|
|
2018
Q4 | $1.42M | Buy |
+5,424
| New | +$1.49M | 0.26% | 101 |
|
|
2018
Q2 | – | Sell |
-33,293
| Closed | -$7.31M | – | 564 |
|
|
2018
Q1 | $7.31M | Buy |
+33,293
| New | +$7.82M | 0.57% | 37 |
|
|
2017
Q4 | – | Sell |
-10,419
| Closed | -$1.98M | – | 541 |
|
|
2017
Q3 | $1.98M | Buy |
+10,419
| New | +$1.98M | 0.25% | 100 |
|
|
2017
Q1 | – | Sell |
-26,304
| Closed | -$3.78M | – | 707 |
|
|
2016
Q4 | $3.78M | Buy |
+26,304
| New | +$3.52M | 0.12% | 189 |
|
|
2015
Q4 | – | Sell |
-3,050
| Closed | -$427K | – | 460 |
|
|
2015
Q3 | $427K | Buy |
+3,050
| New | +$458K | 0.14% | 176 |
|
Other funds holding ELV
Quadrature Capital's ELV Position: Q2 2026 in Review
Quadrature Capital sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 47,340 shares — an estimated $13.9M sold.
Quadrature Capital first reported a position in ELV in Q3 2015 and held it in 26 quarters. The position peaked at $118M in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Quadrature Capital reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Quadrature Capital sold 47,340 Elevance Health shares in Q2 2026, an estimated $13.9M.
- Quadrature Capital first reported a position in Elevance Health in Q3 2015 and held it in 26 quarters.
- Quadrature Capital's Elevance Health position peaked at $118M in Q4 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.